226 related articles for article (PubMed ID: 17218854)
21. Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
Schouten van der Velden AP; van Vugt R; Van Dijck JA; Leer JW; Wobbes T
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):703-10. PubMed ID: 17544591
[TBL] [Abstract][Full Text] [Related]
22. Changes in the management of ductal carcinoma in situ before the release of clinical practice recommendations in Australia: the case in Victoria.
White V; Pruden M; Giles G; Kitchen P; Collins J; Inglis G; Hill D
ANZ J Surg; 2006; 76(1-2):28-34. PubMed ID: 16483292
[TBL] [Abstract][Full Text] [Related]
23. [Ductal cancer in situ in 1990. Review of the literature and comments on a case].
Aublin PC; Aublin C
Rev Fr Gynecol Obstet; 1991; 86(7-9):515-21. PubMed ID: 1661434
[TBL] [Abstract][Full Text] [Related]
24. Ductal carcinoma in situ: morphology-based knowledge and molecular advances.
Ross DS; Wen YH; Brogi E
Adv Anat Pathol; 2013 Jul; 20(4):205-16. PubMed ID: 23752083
[TBL] [Abstract][Full Text] [Related]
25. Current controversies in the treatment of ductal carcinoma in situ of the breast.
Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
[TBL] [Abstract][Full Text] [Related]
26. [Ductal carcinoma in situ: current anatomo-pathologic data].
Fiche M
Rev Med Suisse Romande; 2003 May; 123(5):295-8. PubMed ID: 15095712
[TBL] [Abstract][Full Text] [Related]
27. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
28. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
29. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
30. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
[TBL] [Abstract][Full Text] [Related]
31. Follow-up care of patients with breast cancer.
Tolaney SM; Winer EP
Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
Lagios MD; Page DL; Silverstein MJ
J Clin Oncol; 2006 Aug; 24(23):3809-11; author reply 3811-2. PubMed ID: 16896011
[No Abstract] [Full Text] [Related]
33. Results of 23,810 cases of ductal carcinoma-in-situ.
Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D
Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
[TBL] [Abstract][Full Text] [Related]
34. [Ductal carcinoma in situ: role of the boost].
Azria D; Auvray H; Barillot I; Baumann P; Benyoucef A; Bons-Rosset F; Bontemps P; Bourgier C; Breton-Callu C; Cowen D; Cretin J; Delalande B; Denis F; Ellis S; Gaci Z; Hannoun-Lévy JM; Hasbini A; Hennequin C; Lagrange JL; Lartigau E; Latorzeff I; Le Blanc-Onfroy M; Lecouillard I; Lemanski C; Levy C; Maingon P; Marchal C; Monnier A; Pradier O; Racadot S; Romestaing P; Serin D; Simon JM; Teyssier E; Tallet A; Tolédano A; Belkacémi Y
Cancer Radiother; 2008 Nov; 12(6-7):571-6. PubMed ID: 18703372
[TBL] [Abstract][Full Text] [Related]
35. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
36. Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy.
Rashtian A; Iganej S; Amy Liu IL; Natarajan S
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1016-20. PubMed ID: 18954711
[TBL] [Abstract][Full Text] [Related]
37. Precancerous lesions of the breast.
Costa A; Zanini V
Nat Clin Pract Oncol; 2008 Dec; 5(12):700-4. PubMed ID: 18825141
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
39. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
[TBL] [Abstract][Full Text] [Related]
40. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
